What is Irbesartan?
Irbesartan is a medication used to treat high blood pressure and protect the kidneys in people with type 2 diabetes [1]. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs) [2].
How does Irbesartan work?
Irbesartan works by blocking the action of angiotensin II, a substance in the body that narrows blood vessels [1]. This widening of blood vessels helps to lower blood pressure and improve blood flow [2].
When might generic Irbesartan become available?
The availability of generic versions of prescription drugs like irbesartan typically depends on patent expiration and market exclusivity periods. Companies often work to bring generics to market as soon as these protections expire [3]. Information on specific patent expiry dates for irbesartan can be found through resources like DrugPatentWatch.com [4].
Can I use Irbesartan if I have diabetes?
Yes, irbesartan is specifically indicated for the treatment of kidney disease in patients with type 2 diabetes and high blood pressure [1]. It helps to slow the progression of diabetic nephropathy [1].
What are the common side effects of Irbesartan?
Common side effects of irbesartan can include dizziness, fatigue, and, less commonly, symptoms of a cold or upper respiratory infection [2].
How does Irbesartan compare to other blood pressure medications?
Irbesartan, as an ARB, offers an alternative mechanism to other classes of blood pressure medications like ACE inhibitors, calcium channel blockers, or diuretics. Patients may be prescribed irbesartan if they experience side effects from other drug classes or if other medications are not sufficiently effective [2].
What are the risks associated with Irbesartan?
Irbesartan can cause serious side effects, including a severe allergic reaction, kidney problems, and, in pregnant women, fetal harm or death [2]. It should be used with caution in individuals with certain medical conditions, such as kidney artery stenosis [2].
Where can I find more information on Irbesartan patents?
Detailed information regarding patents for irbesartan, including expiry dates and any legal challenges, is available through specialized databases like DrugPatentWatch.com [4].
Sources:
[1] https://www.ncbi.nlm.nih.gov/books/NBK560548/
[2] https://www.nps.org.au/australian-medicines-handbook/browse/i/irbesartan
[3] https://www.fda.gov/drugs/generic-drugs/what-generic-drug
[4] https://drugpatentwatch.com/